Shi X - Search Results

1

Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals.

Zhong J, Yu X, Dong X, Lu H, Zhou W, Li L, Li Z, Sun P, Shi X. Zhong J, et al. Among authors: shi x. Int J Mol Med. 2018 May;41(5):2893-2900. doi: 10.3892/ijmm.2018.3463. Epub 2018 Feb 6. Int J Mol Med. 2018. PMID: 29436591

2

[The study of the relationship between microlymphatic vessel density and lymph metastasis in hepatocellular carcinoma].

Zhang XK, Zhou WY, Li ZJ, Sun JJ, Zhong WX, Shi XT. Zhang XK, et al. Zhonghua Gan Zang Bing Za Zhi. 2011 Feb;19(2):128-9. doi: 10.3760/cma.j.issn.1007-3418.2011.02.014. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 21492518 Chinese.

3

Significance of the POSSUM scoring system in predicting morbidity and mortality in elderly patients after pancreatoduodenectomy.

Zhong J, Zhao L, Zhou W, Li L, Shi X. Zhong J, et al. Among authors: shi x. Hepatogastroenterology. 2013 Jul-Aug;60(125):1211-6. doi: 10.5754/hge121020. Hepatogastroenterology. 2013. PMID: 23282737

4

TCM matrine inducescell arrest and apoptosis with recovery expression of the hepato-specific miR122a in human hepatocellular carcinomaHep G2cell line.

Zhou W, Xu X, Gao J, Sun P, Li L, Shi X, Li J. Zhou W, et al. Among authors: shi x. Int J Clin Exp Med. 2015 Jun 15;8(6):9004-12. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26309553 Free PMC article.

5

[Current treatment and progress of hepatocellular carcinoma with portal vein tumor thrombus].

Li L, Li Z, Lu H, Zhao L, Shi X. Li L, et al. Among authors: shi x. Zhonghua Wai Ke Za Zhi. 2015 Jun 1;53(6):468-71. Zhonghua Wai Ke Za Zhi. 2015. PMID: 26359063 Chinese.

6

Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells.

Zhong J, Yu X, Dong X, Lu H, Zhou W, Li L, Li Z, Sun P, Shi X. Zhong J, et al. Among authors: shi x. Oncol Lett. 2018 May;15(5):7191-7199. doi: 10.3892/ol.2018.8186. Epub 2018 Mar 7. Oncol Lett. 2018. PMID: 29731881 Free PMC article.

7

T7 peptide cytotoxicity in human hepatocellular carcinoma cells is mediated by suppression of autophagy.

Liu F, Wang F, Dong X, Xiu P, Sun P, Li Z, Shi X, Zhong J. Liu F, et al. Among authors: shi x. Int J Mol Med. 2019 Aug;44(2):523-534. doi: 10.3892/ijmm.2019.4231. Epub 2019 Jun 6. Int J Mol Med. 2019. PMID: 31173192 Free PMC article.

8

Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma.

Zhou Y, Dong X, Xiu P, Wang X, Yang J, Li L, Li Z, Sun P, Shi X, Zhong J. Zhou Y, et al. Among authors: shi x. Oxid Med Cell Longev. 2020 Mar 24;2020:7079308. doi: 10.1155/2020/7079308. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32273947 Free PMC article.

9

Protocol of notable-HCC: a phase Ib study of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma.

Zhang B, Yue J, Shi X, Cui K, Li L, Zhang C, Sun P, Zhong J, Li Z, Zhao L. Zhang B, et al. Among authors: shi x. BMJ Open. 2022 Sep 17;12(9):e060955. doi: 10.1136/bmjopen-2022-060955. BMJ Open. 2022. PMID: 36115673 Free PMC article.

10

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.

Zhang B, Shi X, Cui K, Li Z, Li L, Liu Z, Zhang C, Sun P, Zhong J, Sun Z, Chang Z, Ma Z, Gordon-Weeks A, Li M, Zhao L. Zhang B, et al. Among authors: shi x. BMC Cancer. 2023 May 20;23(1):465. doi: 10.1186/s12885-023-10955-7. BMC Cancer. 2023. PMID: 37210519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,086 results

Search Page

Filters